From: MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients
Clinical variable | Categories | Number of patients |
---|---|---|
T stage | T1-2 | 399 |
 | T3-4 | 40 |
N stage | Nodes uninvolved (N0) | 299 |
 | Nodes involved (N1-2) | 139 |
Tumor grade | Low grade (1) | 60 |
 | Intermediate or high grade (2-3) | 374 |
Our classifier (MAPS) | MAPS- | 229 |
 | MAPS+ (Expressor) | 211 |